Monday, October 1, 2012

Big Pharma Ramps Up Postdoc Programs

‘Pharmaceutical industry watchdogs have long looked to 2012 as the year of the steepest drop off the industry's so-called patent cliff, and so far this year companies have indeed lost a record number of patents on blockbuster drugs. These and other changes in the industry have led to years of lower corporate earnings, massive layoffs (of scientists and other workers), and experiments in outsourcing all sorts of activities that once were done in-house, including early-stage research and development.’

Thinking about a career in industry?  Read this recent Science Careers article about how some of the major pharmaceutical companies are expanding their postdoctoral programs:

No comments:

Post a Comment